Efficacy and safety of bovhyaluronidase azoximer in treatment of chronic endometritis: the Life Cradle open-label comparative randomized controlled trial results

Aim. To assess efficacy and safety of using bovhyaluronidase azoximer (BA) 3000 IU for therapy of chronic endometritis (CE) in patients with the uterine factor infertility. Methods. The data of the open-label independent comparative randomized clinical trial involving 160 women with CE and infertil...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Viktor E. Radzinsky, Mekan R. Orazov, Lyudmila M. Mikhaleva, Elena S. Silantyeva, Roman E. Orekhov, Irina A. Mullina, Rina Yu. Mitrelis
Format:	Artigo
Jezik:	Inglês
Izdano:	LLC "MEDIAFORMAT" 2025-12-01
Serija:	Клинический разбор в общей медицине
Teme:	chronic endometritis combination therapy cd138+ bovhyaluronidase azoximer pelvic inflammatory disease
Online dostop:	https://klin-razbor.ru/en/archive/2025/vol-6-12-2025/efficacy-and-safety-of-bovhyaluronidase-azoximer-in-treatment-of-chronic-endometritis-the-life-cradl_7506/?element
Oznake:	Označite Brez oznak, prvi označite!